SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-23-129205
Filing Date
2023-12-26
Accepted
2023-12-26 16:15:48
Documents
1
Group Members
JEREMY C. GREENREDMILE BIOPHARMA INVESTMENTS II, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2333671d1_sc13da.htm SC 13D/A 87987
  Complete submission text file 0001104659-23-129205.txt   89652
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Subject) CIK: 0001680367 (see all company filings)

IRS No.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91760 | Film No.: 231513504
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)